PERICARDITIS
Clinical trials for PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new PERICARDITIS trials appear
Sign up with your email to follow new studies for PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to stop recurring heart lining pain
Disease control Recruiting nowThis study tests a new medicine called KPL-387 for people who have repeated episodes of pericarditis, a painful inflammation of the lining around the heart. The goal is to see if the drug can reduce flare-ups and pain in patients who still have symptoms despite using standard tre…
Matched conditions: PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 26, 2026 06:14 UTC
-
New hope for heart inflammation sufferers: drug switch study launches
Disease control Recruiting nowThis study tests a new drug, KPL-387, for people with recurrent pericarditis (repeated heart lining inflammation) that is currently well-controlled with standard treatments. About 80 adults will switch from their usual therapy to KPL-387 alone to see if it prevents flare-ups and …
Matched conditions: PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Rare disease mystery: european study seeks to unlock secrets of CACP syndrome
Knowledge-focused Recruiting nowThis study gathers information from people with CACP syndrome, a rare inherited condition that causes finger stiffness, joint swelling, and sometimes heart lining inflammation. Researchers aim to better understand how the disease progresses and how it is currently managed. By col…
Matched conditions: PERICARDITIS
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 06:17 UTC
-
New registry tracks rare heart side effects of COVID shots
Knowledge-focused Recruiting nowThis study looks at people who developed heart inflammation (myocarditis or pericarditis) after getting a COVID-19 vaccine. Researchers will review medical records and follow up with 400 participants for up to 4 years to understand long-term health outcomes. The goal is to learn …
Matched conditions: PERICARDITIS
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC